Axxess Pharma Inc (OTCMKTS:AXXE) a Pharma and nutritional supplements company announced that it finalized a long-term marketing, manufacturing, and distribution deal with 8E6Tong Private Company Ltd. It is a Singapore-registered firm with a facility based in Tongxiang, China. Recently, Axxess also finalized a major promotional deal with ROC Nation.

The terms

As per the deal, Tong will be introducing its own product line of products utilizing Axxess ‘patented formula. The products will be offered online across globe. They will also be available for sale on selected retail outlets. It forecast minimum sales of $525,000 in the first year and $4.3 million in the first five year period of the license. The specialized firm is active in the segment of production, distribution and marketing of health sciences products to enhance the quality of life. Tong’s facility makes use of environmental science and green chemistry.

The expert speaks

The management of Axxess Pharma said that the deal with Tong is a major achievement for the company and validates the significance of the intellectual property. The company expects the revenue to begin in 3Q2015. Axxess operates through its Canadian subsidiary firm headquartered in Toronto. It is dedicated to enhance health and quality of life by developing nutritional supplements, effective medicines and over the counter medications all across the U.S. The objective is to develop innovative products for better health. Also, the focus is on health management using improved nutritional supplements. It keeps on entering into new deals to expand its offerings into the market.

The momentum

In last trading session, the stock price of Axxess Pharma Inc (OTCMKTS:AXXE) surged more than 15% to close the trading session at $0.0850. The gains came at a share volume of 1.62 million compared to average share volume of 1.53 million. The high for the day was $0.09 and the low was $0.07. The market cap stands at 4.22 million.

Previous articleGoldman Small Cap research Issues Research Article On Pharmacyte Biotech Inc (OTCMKTS:PMCB)
Next articleCannabis Science Inc (OTCMKTS:CBIS) Erases Early Gains
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg,,, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.